It is always frustrating to see hair reappear just a few days after hair removal, which explains the growing interest in hair regrowth‑inhibiting products, whether creams, lotions, serums that inhibit hair regrowth, or oils that inhibit hair regrowth. These treatments, presented as solutions capable of slowing down hair growth, are theoretically based on a modulation of the hair cycle, more specifically on a prolongation of the telogen phase, or resting phase, or a slowing of the anagen phase, which corresponds to the hair growth phase.
Some claims also put forward an effect on the very structure of the hair shaft, in particular via an alteration of keratin synthesis, the main fibrous protein of the hair produced by keratinocytes in the hair follicle, which could lead to finer, less pigmented hairs that may become less visible over successive cycles. Other hypotheses suggest an interaction with signalling pathways involved in the proliferation of matrix cells in the hair bulb, but these mechanisms remain largely speculative.
Despite a booming market for hair regrowth-inhibiting products, scientific data remain limited.
Can wax tree extract slow down hair regrowth?
Frequently cited in anti-regrowth hair treatment formulas, wax tree extract, more precisely the insect wax secreted by Ericerus pela, is in fact far from having demonstrated any inhibitory effect on hair growth. On the contrary, the available scientific data rather suggest a stimulatory effect on the hair follicle. Indeed, certain experimental studies show that the topical application of this wax promotes the transition of the follicle from the telogen phase to the anagen phase. This stimulation is notably accompanied by an increased expression of the growth factor VEGF, thereby improving the supply of nutrients and oxygen necessary for hair growth.
These observations were confirmed by an in vivo study conducted in mice, in which different concentrations of insect wax (30% and 45%) were applied to depilated areas and compared with a positive control consisting of 5% minoxidil, a drug used to treat alopecia. From day 16 onwards, visible hair regrowth was observed in the treated groups, in contrast to the control group. Hair lengths measured in the 30% and 45% groups were significantly greater than those in the control group on days 16 and 20, with performance close to that of minoxidil. Histological analysis showed that this effect did not rely on the formation of new follicles, but on a premature conversion of existing follicles from the telogen phase to the anagen phase, as well as a prolongation of this growth phase. This activity appears to be linked in particular to increased expression of VEGF and to the presence of policosanols in the wax, identified as major active compounds.